IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Effector Therapeutics Inc (EFTR)

CUSIP: 28202V207 | NYSE | Healthcare · Biotechnology | Micro Cap | 26 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Proathlete Wealth Management LLC12
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Proathlete Wealth Management LLC
12$00.0%ETFVery LowBoca Raton, FL2026-10-15